Clapp, Mark A. http://orcid.org/0000-0001-5568-4444
McCoy Jr, Thomas H.
James, Kaitlyn E.
Kaimal, Anjali J.
Roy H. Perlis,
Article History
Received: 21 October 2020
Revised: 16 March 2021
Accepted: 26 April 2021
First Online: 19 May 2021
Compliance with ethical standards
:
: Dr. Perlis has received fees for consulting or service on scientific advisory boards for Genomind, Psy Therapeutics, Outermost Therapeutics, RID Ventures, and Takeda. He has received patent royalties from Massachusetts General Hospital. He holds equity in Psy Therapeutics and Outermost Therapeutics.